跳至主要内容
临床试验/JPRN-UMIN000003546
JPRN-UMIN000003546已完成1 期

PhaseI/II trial of chemotherapy with docetaxel, CDDP and 5-Fluorouracil followed by chemoradiotherapy with CDDP and 5-Fluorouracil in patients with locally advanced esophageal cancer. - PhaseI/II trial of induction chemotherapy with DCF and definite chemoradiotherapy with FP in patients with locally advanced esophageal cancer.

Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University0 个研究点目标入组 60 人开始时间: 2010年5月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.History of hypersensitivity to DOC, CDDP, 5-FU, or polysorbate 80 2.With severe complication 3.Infection with fever elevation 4.Motor paralysis, peripheral neuropathy or edema 5.Pleural or pericardial effusion that requires treatment 6.Simultaneous or metachronous (within 5 years) double cancers. 7.Pregnant or lactating women 8.Interstitial pneumonia or fibroid lung 9.Psychosis

研究者

发起方
Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University

相似试验

已完成
2 期
the phase II study of chemotherapy with Docetaxel+Nedaplatin+5-FU(DNF) to esophageal cancerStageII,III,IV non-resective esophageal cancer and recurrece ofesophageal cancer
JPRN-UMIN000005081Gunma University Graduate School Department of General Surgical Science30
已完成
不适用
the phase I study of chemotherapy with Docetaxel+Nedaplatin+5-FU(DNF) to esophageal cancerStageII,III,IV non-resective esophageal cancer and recurrece ofesophageal cancer
JPRN-UMIN000005083Gunma University Graduate School Department of General Surgical Science18
进行中(未招募)
1 期
First Line Dose-Dense Chemotherapy With Docetaxel, Cisplatin, Folinic Acid and 5- Fluorouracil plus Panitumumab in Patients With Locally Advanced or Metastatic Cancer of the Stomach or Gastro-Esophageal Junction: A Phase II Multicentre Trial - GOIRC 02/2009Patients with metastatic or locally advanced not resectable cancer of the stomach or gastro-esophageal junction.MedDRA version: 9.1Level: PTClassification code 10017758MedDRA version: 9.1Level: HLTClassification code 10030176
EUCTR2009-016962-10-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA52
已完成
不适用
Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.Breast cancer
JPRN-UMIN000002310Gunma Breast Cancer Research Group 2 surgery90
进行中(未招募)
不适用
Induction chemotherapy with docetaxel and cisplatin followed by radiotherapy concomitant with cetuximab for locally advanced stage III non-small cell lung cancer- amulticentre, open label non-randomised phase II trial - SatellitPatient with locally advanced stage III non-small cell lung cancer.
EUCTR2005-003867-21-SESahlgrenska University Hospital75